Literature DB >> 30905178

Effects of Oral Meloxicam and Topical Lidocaine on Pain associated Behaviors of Piglets Undergoing Surgical Castration.

M C Burkemper1, M D Pairis-Garcia1, L E Moraes1, R M Park2, S J Moeller1.   

Abstract

The objective of this study was to find a practical means of reducing pain associated with surgical castration by evaluating the effects of oral meloxicam and topical lidocaine, separately and in combination, on behavioral indicators of pain in piglets. Two hundred thirty-five piglets were surgically castrated between three and seven days of age. Immediately following castration, piglets received one of four treatments: (1) No pain mitigation (C; control; n = 58); (2) NSAID only (M; meloxicam; n = 59); (3) Topical anesthetic (L; lidocaine spray; n = 60); or (4) NSAID and topical anesthetic (X; meloxicam and lidocaine spray; n = 59). Behaviors were recorded by direct observation of individual piglets using five-minute scan samples over a five-hour period, for three days post-castration. Results of the experiment demonstrate the administration of oral meloxicam and topical lidocaine spray at the time of castration under the current methods did not mitigate pain associated with the procedure (P = 0.09; C: 2.1 ± 0.1, L: 2.4 ± 0.1, M: 2.1 ± 0.1 and X: 2.1 ± 0.1).

Entities:  

Keywords:  castration; lidocaine; meloxicam; pain; piglet

Year:  2019        PMID: 30905178     DOI: 10.1080/10888705.2019.1590717

Source DB:  PubMed          Journal:  J Appl Anim Welf Sci        ISSN: 1088-8705            Impact factor:   1.440


  2 in total

1.  Topical wound anaesthesia: efficacy to mitigate piglet castration pain.

Authors:  M L Sheil; M Chambers; B Sharpe
Journal:  Aust Vet J       Date:  2020-02-24       Impact factor: 1.281

2.  On the Road to End Pig Pain: Knowledge and Attitudes of Brazilian Citizens Regarding Castration.

Authors:  Maria José Hötzel; Maria Cristina Yunes; Bianca Vandresen; Rita Albernaz-Gonçalves; Raphaela E Woodroffe
Journal:  Animals (Basel)       Date:  2020-10-08       Impact factor: 2.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.